(NASDAQ: TYRA) Tyra Biosciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.94%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.52%.
Tyra Biosciences's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast TYRA's revenue for 2026 to be $554,622,288, with the lowest TYRA revenue forecast at $554,622,288, and the highest TYRA revenue forecast at $554,622,288. On average, 3 Wall Street analysts forecast TYRA's revenue for 2027 to be $4,062,818,344, with the lowest TYRA revenue forecast at $2,766,283,704, and the highest TYRA revenue forecast at $4,971,117,383.
In 2028, TYRA is forecast to generate $13,504,369,939 in revenue, with the lowest revenue forecast at $10,480,575,528 and the highest revenue forecast at $19,526,275,969.